Platelet isolation

MP Mariana Brandi Mendonça Pinheiro
SR Stephane Vicente Rozini
AQ Anna Cecíllia Quirino-Teixeira
GB Giselle Barbosa-Lima
JL Juliana F. Lopes
CS Carolina Q. Sacramento
FB Fernando A. Bozza
PB Patrícia T. Bozza
EH Eugenio D. Hottz
request Request a Protocol
ask Ask a question
Favorite

Platelet isolation was performed as previously described (29). Peripheral blood samples were drawn into acid-citrate-dextrose (ACD) and centrifuged at 200 x g for 20 min. Platelet-rich plasma (PRP) was obtained and recentrifuged (500 X g, 20 min) in the presence of 100 nM of prostaglandin E1 (PGE1; Cayman 1303) to pellet the platelets. Platelet pellets were resuspended in 25 ml of PSG (5 mM PIPES, 145 mM 35 NaCl, 4 mM KCl, 50 μM Na2HPO4, 1 mM MgCl2·6H2O, 5,5 mM glucose; pH 6,8) containing 100 nM PGE1. The platelet suspension was centrifuged again at 500 X g for 20 min and the platelet pellet was resuspended in medium 199 (M199) containing 25 mM of HEPES to the concentration of 1 x 109/mL. The platelet viability in dengue patients and healthy volunteers in the present study has been previously reported (26). The viability of platelets used for in vitro experiments was above 95% of live platelets.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A